Welcome to LookChem.com Sign In|Join Free
  • or
4-((3-((dimethylamino)methyl)-2-methyl-1H-indol-1-yl)methyl)-N-hydroxybenzamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1392835-46-9

Post Buying Request

1392835-46-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1392835-46-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1392835-46-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,9,2,8,3 and 5 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1392835-46:
(9*1)+(8*3)+(7*9)+(6*2)+(5*8)+(4*3)+(3*5)+(2*4)+(1*6)=189
189 % 10 = 9
So 1392835-46-9 is a valid CAS Registry Number.

1392835-46-9Downstream Products

1392835-46-9Relevant academic research and scientific papers

Ring-opened tetrahydro-γ-carbolines display cytotoxicity and selectivity with histone deacetylase isoforms

Nepali, Kunal,Lee, Hsueh-Yun,Lai, Mei-Jung,Ojha, Ritu,Wu, Tung-Yun,Wu, Gu-Xian,Chen, Mei-Chuan,Liou, Jing-Ping

, p. 115 - 127 (2017)

This study is focused on modification of the indole moiety and the N1-zinc binding domain of tubastatin A, and the effects of such changes on biological activity. Fourteen N-substituted indoles (5–18) were synthesized and structure-activity relationship studies indicated that the change of the tetrahydro-γ-carboline in tubastatin A led to substituted indoles (compounds 7, 11, and 15) which showed significant improvements of selective inhibition for HDAC6 over HDAC1 and HDAC2 in comparison to ACY1215, a compound undergoing clinical trials. In addition, attachment of different hydroxamic acid groups, the zinc binding motif at the N1 position, contributes to the antiproliferative activity in cancer cells. Several synthetic compounds exhibited potent growth inhibition in a broad spectrum of tumor cell lines, induced irreversible growth arrest capacities by suppressing colony formation ability and activated the apoptosis pathway. The data provide compelling evidence that our newly synthesized compounds with type B to D hydroxamic acid groups as the zinc binding motif at the N1 position are potent selective inhibitors of HDAC6 and could be investigated preclinically as potential anticancer drugs.

HDAC INHIBITORS AND THERAPEUTIC METHODS USING THE SAME

-

Page/Page column 56, (2012/08/27)

Histone deacetylases inhibitors (HDACIs) and compositions containing the same are disclosed. Methods of treating diseases and conditions wherein inhibition of HDAC provides a benefit, like a cancer, a neurodegenerative disorder, a peripheral neuropathy, a neurological disease, traumatic brain injury, stroke, hypertension, malaria, an autoimmune disease, autism, autism spectrum disorders, and inflammation, also are disclosed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1392835-46-9